Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men.

[1]  J. Newman,et al.  Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers[S] , 2012, Journal of Lipid Research.

[2]  T. Hankemeier,et al.  Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: application in cardiac surgery , 2012, Analytical and Bioanalytical Chemistry.

[3]  M. Spite,et al.  Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. , 2012, Annual review of nutrition.

[4]  D. Bishop-Bailey,et al.  Anti-Inflammatory Effects of Epoxyeicosatrienoic Acids , 2012, International journal of vascular medicine.

[5]  F. Haj,et al.  Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes , 2012, Proceedings of the National Academy of Sciences.

[6]  S. Dimmeler,et al.  Soluble epoxide hydrolase regulates hematopoietic progenitor cell function via generation of fatty acid diols , 2012, Proceedings of the National Academy of Sciences.

[7]  O. D. Rangel-Huerta,et al.  Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials , 2012, British Journal of Nutrition.

[8]  R. Ortega,et al.  Effects of omega 3 fatty acids supplementation in behavior and non-neurodegenerative neuropsychiatric disorders , 2012, British Journal of Nutrition.

[9]  P. Pérez-Martínez,et al.  Long chain omega-3 fatty acids and cardiovascular disease: a systematic review , 2012, British Journal of Nutrition.

[10]  S. Takeda,et al.  5-Hydroxy-eicosapentaenoic acid is an endogenous GPR119 agonist and enhances glucose-dependent insulin secretion. , 2011, Biochemical and biophysical research communications.

[11]  J. Newman,et al.  Effects of dynamic exercise on plasma arachidonic acid epoxides and diols in human volunteers. , 2011, International journal of sport nutrition and exercise metabolism.

[12]  M. Holinstat,et al.  12-lipoxygenase: a potential target for novel anti-platelet therapeutics. , 2011, Cardiovascular & hematological agents in medicinal chemistry.

[13]  K. Weylandt,et al.  Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples. , 2011, Prostaglandins & other lipid mediators.

[14]  B. Hammock,et al.  Investigation of human exposure to triclocarban after showering and preliminary evaluation of its biological effects. , 2011, Environmental science & technology.

[15]  B. Hammock,et al.  Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP , 2011, Proceedings of the National Academy of Sciences.

[16]  U. Laufs,et al.  Cardiovascular disease and dyslipidemia: beyond LDL. , 2011, Current pharmaceutical design.

[17]  B. McManus,et al.  The Human Serum Metabolome , 2011, PloS one.

[18]  M. Merkel,et al.  Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters , 2011, European Journal of Clinical Nutrition.

[19]  B. Hammock,et al.  Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids[S] , 2010, Journal of Lipid Research.

[20]  G. Wallukat,et al.  Arachidonic Acid-metabolizing Cytochrome P450 Enzymes Are Targets of ω-3 Fatty Acids* , 2010, The Journal of Biological Chemistry.

[21]  W. Harris,et al.  Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters[S] , 2010, Journal of Lipid Research.

[22]  W. Schunck,et al.  Cytochrome P450-dependent metabolism of ω-6 and ω-3 long-chain polyunsaturated fatty acids , 2010 .

[23]  Takashi Suzuki,et al.  Identification and absolute configuration of dihydroxy-arachidonic acids formed by oxygenation of 5S-HETE by native and aspirin-acetylated COX-2 , 2010, Journal of Lipid Research.

[24]  T. Mori,et al.  Omega-3 fatty acids and blood pressure. , 2010, Cellular and molecular biology.

[25]  W. Gade,et al.  Beyond Obesity: The Diagnosis and Pathophysiology of Metabolic Syndrome , 2010, American Society for Clinical Laboratory Science.

[26]  W. Schunck,et al.  Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids. , 2010, Pharmacological reports : PR.

[27]  Jun Yang,et al.  Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry. , 2009, Analytical chemistry.

[28]  S. Cunnane,et al.  alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[29]  Dennis,et al.  An integrated omics analysis of eicosanoid biology. , 2009 .

[30]  S. Cunnane,et al.  ISSFAL Official Statement Number 5 α – Linolenic Acid Supplementation and Conversion to n-3 Long Chain Polyunsaturated Fatty Acids in Humans , 2009 .

[31]  J. Newman,et al.  Lipoprotein lipase releases esterified oxylipins from very low-density lipoproteins. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[32]  E. Oliw,et al.  Enantiomeric separation and analysis of unsaturated hydroperoxy fatty acids by chiral column chromatography-mass spectrometry. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[33]  J. Whelan.  The health implications of changing linoleic acid intakes. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[34]  I. Fleming.  Vascular cytochrome p450 enzymes: physiology and pathophysiology. , 2008, Trends in cardiovascular medicine.

[35]  E. Niki.  Lipid peroxidation products as oxidative stress biomarkers , 2008, BioFactors.

[36]  T. Goodfriend,et al.  Heparin, lipoproteins, and oxygenated fatty acids in blood: a cautionary note. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[37]  S. Cunnane,et al.  Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. , 2007, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[38]  J. Falck,et al.  Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors. , 2007, Hypertension.

[39]  T. L. Goodfrienda,et al.  Heparin , lipoproteins , and oxygenated fatty acids in blood : A cautionary note , 2007 .

[40]  P. Calder,et al.  Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. , 2005, Reproduction, nutrition, development.

[41]  V. Ziboh,et al.  15-lipoxygenase metabolites of gamma-linolenic acid/eicosapentaenoic acid suppress growth and arachidonic acid metabolism in human prostatic adenocarcinoma cells: possible implications of dietary fatty acids. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[42]  B. Hammock,et al.  Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. , 2005, Annual review of pharmacology and toxicology.

[43]  W. Harris,et al.  The Omega-3 Index: a new risk factor for death from coronary heart disease? , 2004, Preventive medicine.

[44]  J. Tímár,et al.  12-Lipoxygenases and 12(S)-HETE: role in cancer metastasis , 1994, Cancer and Metastasis Reviews.

[45]  Tracey McLaughlin,et al.  Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant , 2003, Annals of Internal Medicine.

[46]  D. Kroetz,et al.  Cytochrome P450 pathways of arachidonic acid metabolism , 2002, Current opinion in lipidology.

[47]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[48]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[49]  A. Brash.  Lipoxygenases: Occurrence, Functions, Catalysis, and Acquisition of Substrate* , 1999, The Journal of Biological Chemistry.

[50]  E. Oliw,et al.  Cytochromes P450 with bisallylic hydroxylation activity on arachidonic and linoleic acids studied with human recombinant enzymes and with human and rat liver microsomes. , 1998, The Journal of pharmacology and experimental therapeutics.

[51]  H. D. Liggitt,et al.  In vivo chemotaxis of bovine neutrophils induced by 5-lipoxygenase metabolites of arachidonic and eicosapentaenoic acid. , 1989, The American journal of pathology.

[52]  A. A. Spector,et al.  Hydroxyeicosatetraenoic acids (HETEs). , 1988, Progress in lipid research.

[53]  K. Austen,et al.  Arachidonic acid metabolism by the 5-lipoxygenase pathway, and the effects of alternative dietary fatty acids. , 1986, Advances in immunology.

[54]  W. Stenson,et al.  Prostaglandins, macrophages, and immunity. , 1980, Journal of immunology.

[55]  D. Nelson.  Macrophages and immunity , 1969 .

[56]  T. Kotchen.  Prostaglandins. , 1968, JAMA.